Size | Price | Stock | Qty |
---|---|---|---|
100mg |
|
||
Other Sizes |
|
ln Vitro |
Pyridaben (0-10 µM; 3 min) combines with brain submitochondrial granules' complexes I–III of the factor receptor [1]. With malate-glutamate as the substrate, pyridaben (0–10 µM; 3 min) significantly reduces the respiratory control of brain mitochondria in a dose-dependent manner (IC50= 1.7 µM) [1]. When malate-glutamic acid is the substrate, pyridoglutaben (0–10 µM; 3 min) dramatically lowers the functional activity of mtNOS; however, this effect is not observed when succinate is the substrate [1].
|
---|---|
Cell Assay |
Cell Viability Assay [1]
Cell Types: Rat Brain Cartilage Pellets Tested Concentrations: 0-10 µM Incubation Duration: 3 minutes Experimental Results: Result in decrease in NADH-cytochrome reductase activity (complex I-III), but not succinate-cytochrome c Reductase activity (complex II-III) and cytochrome oxidase activity (complex IV) did not modify cell viability assay [1] Cell Types: Rat brain mitochondria Tested Concentrations: 0-10 µM Incubation Duration: 3 minutes Experimental Results: In the presence of malate-glutamate as substrate, respiratory control shows a significant and dose-dependent decrease (IC50=1.7 µM) |
References |
[1]. Gomez C,et al. Pesticides and impairment of mitochondrial function in relation with the parkinsonian syndrome. Front Biosci. 2007 Jan 1;12:1079-93.
[2]. Namin HH, et al. Resistance to pyridaben in Canadian greenhouse populations of two-spotted spider mites, Tetranychus urticae (Koch). Pestic Biochem Physiol. 2020 Nov;170:104677. |
Molecular Formula |
C19H25CLN2OS
|
---|---|
Molecular Weight |
364.93
|
Exact Mass |
364.1376
|
CAS # |
96489-71-3
|
Related CAS # |
Pyridaben-d13;2468638-05-1
|
Appearance |
Typically exists as solids (or liquids in special cases) at room temperature
|
SMILES |
CC(C)(C)C1=CC=C(C=C1)CSC2=C(C(=O)N(C(C)(C)C)N=C2)Cl
|
Synonyms |
Pyridaben Sanmite
|
HS Tariff Code |
2934.99.9001
|
Storage |
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month Note: This product requires protection from light (avoid light exposure) during transportation and storage. |
Shipping Condition |
Room temperature (This product is stable at ambient temperature for a few days during ordinary shipping and time spent in Customs)
|
Solubility (In Vitro) |
DMSO : ~50 mg/mL (~137.01 mM)
|
---|---|
Solubility (In Vivo) |
Solubility in Formulation 1: ≥ 2.5 mg/mL (6.85 mM) (saturation unknown) in 10% DMSO + 90% (20% SBE-β-CD in Saline) (add these co-solvents sequentially from left to right, and one by one), clear solution.
For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of 20% SBE-β-CD physiological saline solution and mix evenly. Preparation of 20% SBE-β-CD in Saline (4°C,1 week): Dissolve 2 g SBE-β-CD in 10 mL saline to obtain a clear solution. Solubility in Formulation 2: ≥ 2.5 mg/mL (6.85 mM) (saturation unknown) in 10% DMSO + 90% Corn Oil (add these co-solvents sequentially from left to right, and one by one), clear solution. For example, if 1 mL of working solution is to be prepared, you can add 100 μL of 25.0 mg/mL clear DMSO stock solution to 900 μL of corn oil and mix evenly.  (Please use freshly prepared in vivo formulations for optimal results.) |
Preparing Stock Solutions | 1 mg | 5 mg | 10 mg | |
1 mM | 2.7403 mL | 13.7013 mL | 27.4025 mL | |
5 mM | 0.5481 mL | 2.7403 mL | 5.4805 mL | |
10 mM | 0.2740 mL | 1.3701 mL | 2.7403 mL |
*Note: Please select an appropriate solvent for the preparation of stock solution based on your experiment needs. For most products, DMSO can be used for preparing stock solutions (e.g. 5 mM, 10 mM, or 20 mM concentration); some products with high aqueous solubility may be dissolved in water directly. Solubility information is available at the above Solubility Data section. Once the stock solution is prepared, aliquot it to routine usage volumes and store at -20°C or -80°C. Avoid repeated freeze and thaw cycles.
Calculation results
Working concentration: mg/mL;
Method for preparing DMSO stock solution: mg drug pre-dissolved in μL DMSO (stock solution concentration mg/mL). Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug.
Method for preparing in vivo formulation::Take μL DMSO stock solution, next add μL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O,mix and clarify.
(1) Please be sure that the solution is clear before the addition of next solvent. Dissolution methods like vortex, ultrasound or warming and heat may be used to aid dissolving.
(2) Be sure to add the solvent(s) in order.